The plant investigation is in process.
A supplemental mdr will be submitted upon completion of this activity.
Clinical investigation: a temporal relationship exists between hd therapy utilizing the fresenius combi set bloodlines, optiflux 160nre dialyzer and the serious adverse events of dialyzer reaction, wheezing and anxiety, which required emergent discontinuation of hd therapy.
The definitive etiology of the events is unknown; therefore, causality cannot be firmly established.
However, given the patient¿s wheezing and anxiety during hd therapy, a possible causal or contributory role cannot be excluded.
Based on the information available, the fresenius combi set bloodlines and/or optiflux 160nre dialyzer cannot be disassociated from the events.
While uncommon, hypersensitivity reactions are known to occur with the use of optiflux dialyzers and/or other elements in the extracorporeal circuit.
Additionally, hypersensitivity reactions have been known to occur days, months, even years after use with the same dialyzer model.
|
It was reported that a hemodialysis (hd) patient experienced a suspected allergic reaction (per the nephrologist) to the fresenius combi set bloodlines.
Follow-up with the patient¿s inpatient dialysis program manager (idpm) revealed the patient was hospitalized on (b)(6) 2020 for hyperkalemia, acute kidney failure (due to cancer, specifics not provided) and dyspnea.
On (b)(6) 2020, the patient underwent a temporary hemodialysis (hd) catheter (not a fresenius product) placement and was started on intermittent hd while being monitored by telemetry in the intensive care unit (icu).
The patient was alert and oriented, and after hd was initiated on (b)(6) 2020, the patient began wheezing and feeling an overwhelming sense of anxiety or ¿impending doom.
¿ initially it was felt the patient may be having a reaction to the fresenius combi set bloodlines, however further evaluation revealed the likely source of the allergic reaction to be caused by the sterilization methods of the optiflux 160nre dialyzer.
The patient¿s treatment was discontinued; however no additional information was provided.
The treatment record was requested; however, the request was declined.
The combi set product information was not provided.
|